FDA Provides Highlights on Implementation of Landmark Cosmetics Legislation
Advocacy & Action
Canadian Environmental Sustainability Indicator (CESI) Spring 2026 Newsletter
Publication of the Watch List Approach
Update on the Canadian Safety Pledge
Update on Monograph Initiative
NNHPD Performance Standards
IFRA Information Letter n° 1235 – Tonalide – ECHA RAC Opinion as Repr. 1B Adopted
SCCS – Opinion on the safety of Heliotropin Used in Cosmetic Products (CAS No. 120-57-0, EC No. 204-409-7)
Explanatory Notes for Drug Establishments on the Preparation of a Site Master File (GUI-0005)
Ad Standards Publishes New Guidance on Environmental Claims in Advertising
